Berta Sanchez-Laorden

8PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMolecular targetsSensory systemsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 04, 2026
A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential.

Raúl Jiménez-Castaño, Nitin Narwade, Gema Moreno-Bueno

|Jul 04, 2025
Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity.

Adrián Varela-Vázquez, Amanda Guitián-Caamaño, Paula Carpintero-Fernández

|Mar 04, 2025
Schwann cells in regeneration and cancer: an epithelial-mesenchymal transition perspective.

Francisco Gracia, Berta Sanchez-Laorden, Jose A Gomez-Sanchez

|Aug 10, 2023
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Marta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz

|Jul 29, 2023
Microenvironmental Snail1-induced immunosuppression promotes melanoma growth.

Marta Arumi-Planas, Francisco Javier Rodriguez-Baena, Francisco Cabello-Torres

|Feb 14, 2022
Antifibrotic drugs as therapeutic tools in resistant melanoma.

Berta Sanchez-Laorden, M Angela Nieto

Pageof 2

Frequent Collaborators

3 joint publications

M Angela Nieto

2 joint publications

Nicolas Macagno

2 joint publications

Richard Marais

2 joint publications

Francisco Javier Rodriguez-Baena